Raekwon McMillan

Linebacker

Age: 28
Free Agency: 2025 (UFA)
Accrued Seasons: 7
  • 2024 Salary Cap Charge: $1,275,000 (0.48% of cap)
  • 2024 Cash Payout: $1,645,000 (0.60% of spending)
  • 2024 Cash to Cap Ratio: 1.29
  • Contract Value: $2,990,000 ($1,495,000 APY)
  • Fully Guaranteed Money: $905,000
  • Contract Ranking: 69/250 at LB

Current Contract

(Other, signed 2023)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusRoster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
RegularPer Game
202327$1,080,000$245,000$0$0$20,000$330,000$1,345,0000.6%
2024 📝
March 16: $100,000 roster bonus due
28$1,125,000$0$215,000$255,000$50,000$330,000$1,275,0000.5%
Total$2,205,000$245,000$215,000$255,000$70,000$660,000$2,620,000

Contract Notes

Raekwon McMillan signed a 1 year, $1.6 million contract with the Patriots. The contract has $575,000 in guarantees. Another $600,000 in incentives are available.

Cash Flows

- fully earned money
- unearned or partially earned money
$1.5M
$3M
20232024
Cash Due$1,345,000$1,645,000
Running Cash$1,345,000$2,990,000
Career Earnings: $7,866,946
Career APY: $1,123,849
Potential Earnings: $9,511,946
Total Guarantees: $7,329,824
Largest Cash Payment: $2,021,388 (2017)
Largest Cap Number: $1,345,000 (2023)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
DolphinsDraftedTraded20174$4,697,534$1,174,384$2,699,912$3,591,96176.5%$1,197,320
RaidersDraftedExpired20174$4,697,534$1,174,384$2,699,912$1,105,57323.5%$1,105,573
PatriotsUFARenegotiated20211$1,150,000$1,150,000$250,000$00.0%$0
PatriotsOtherExpired20212$2,170,000$1,085,000$200,000$1,824,41284.1%$912,206
PatriotsUFARenegotiated20231$1,600,000$1,600,000$575,000$00.0%$0
PatriotsOtherActive20232$2,990,000$1,495,000$905,000$1,345,00045.0%$1,345,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Dolphins3$3,591,961$1,197,320$3,202,8630.0%$389,0970.0%
Raiders1$1,105,573$1,105,573$1,105,5730.0%$00.0%
Patriots3$3,169,412$1,056,471$3,069,4120.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2017Dolphins$465,000$389,097$0$0$0$465,000$854,0970.5%$2,021,388
2018Dolphins$678,524$389,097$0$0$0$678,524$1,067,6210.6%$678,524
2019Dolphins$892,048$389,097$0$0$0$0$1,281,1450.7%$892,049
2020Raiders$1,105,573$0$0$0$0$0$1,105,5730.5%$1,105,573
2021Patriots$920,000$50,000$0$0$0$100,000$540,0000.3%$540,000
2022Patriots$965,000$0$50,000$180,000$0$100,000$1,184,4120.6%$1,284,412
2023Patriots$1,080,000$245,000$0$0$20,000$330,000$1,345,0000.6%$1,345,000
2024Patriots$1,125,000$0$215,000$255,000$50,000$330,000$1,275,0000.5%$1,645,000
Total$7,231,145$1,462,291$265,000$435,000$70,000$2,003,524$8,652,848$9,511,946
Dead Money History
TeamYearCap ChargeCash Paid
Dolphins2020$389,097$0
Total$389,097$0

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
2018160076.1%3.8%693600501002100
2019133046.4%36.8%353700321000000
2020160015.5%61.5%14900101001000
2022161022.1%60.6%23919510000100

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$0$0
Injury Adjusted$0$0
test
OTC Valuation $3.1M $6.1M $9.2M $12.2M $15.3M APY $3.3M $6.7M $10M $13.3M $16.7M $4,826,000 $3,000,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.